Assesment of Gingival Crevicular Fluid and Serum ErbB4/Neuregulin-4 Levels in Periodontal Disease and Health
NCT ID: NCT04051385
Last Updated: 2019-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2018-04-02
2019-01-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Non-Surgical Periodontal Treatment on Gingival Crevicular Fluid and Serum Biomarker Levels
NCT06175624
Evaluation of Biomarker Levels in Gingival Crevicular Fluid of Patients With Different Periodontal Diseases
NCT04777487
GCF Annexin-A1, Carbonic Anhydrase-1, and Elongation Factor-1 Gamma Levels in Periodontitis
NCT05680441
GCF Galectin-3 and Interleukin-1beta Levels in Periodontitis.
NCT05449093
Gingival Crevicular Fluid, Salivary, and Serum Biomarkers Levels in Periodontal Treatment
NCT05395455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The participants were classified into four groups depending on periodontal health status in accordance with the consensus reports of the 2017 World Workshop:
1. periodontally healthy (H) group: no interproximal attachment loss (AL), probing depth (PD) ≤3 mm, bleeding on probing (BOP) scores \<10%;
2. gingivitis (G) group: no interproximal AL, PD ≤3 mm, and BOP ≥10%;
3. stage II grade B periodontitis (P1) group: 3 \<PD ≤5 mm and 3 ≤ clinical attachment loss (CAL) \<5 mm in one or more sites of the 2 non-adjacent teeth in at least two quadrants of the mouth, full mouth BOP ≥ 10% and no tooth loss due to periodontitis
4. stage III grade B periodontitis (P2) group: PD \>5 mm and CAL ≥ 5 mm in one or more sites of the 2 non-adjacent teeth in at least two quadrants of the mouth, full mouth BOP \>10% and tooth loss due to periodontitis of ≤4 teeth.
Inclusion criteria were as follows:
1. aged \>18 years,
2. having at least 16 natural teeth (excluding third molar),
3. not having any diagnosed medical illness or drug intake that could affect the periodontal condition.
Exclusion criteria were as follows:
1. The patients who had taken antibiotics, nonsteroidal antiinflammatory or any other drugs within the past 3 months,
2. received nonsurgical or surgical periodontal treatment,
3. a restorative and endodontic therapy requirement,
4. a removable partial denture and/or having orthodontic therapy
5. Current pregnancy or lactation, obesity, heavy smoking and having serum C reactive protein (CRP) \> 3mg/L.
All individuals were examined at baseline and four weeks after non-surgical periodontal treatment including, whole mouth probing depth (PD), CAL, presence of bleeding on probing (BOP), papillar bleeding index (PBI), gingival index (GI) and plaque index (PI) except the third molars. PD and CAL were measured at six sites per tooth using a manual periodontal probe.
The non-surgical periodontal treatment for P1 and P2 groups included supra- and subgingival scaling, root planing and oral hygiene instructions. Subgingival scaling and root planing were performed under local anesthesia in two sessions within the 48-72 h. Gingivitis group had supra-and subgingival scaling, polishing and oral hygiene instructions. The treatment of gingivitis and periodontitis patients were performed by a periodontist (BM) using hand and ultrasonic instruments. All measurements were performed by the same calibrated examiner (BM).
Gingival crevicular fluid (GCF) sampling
GCF samples were obtained from four nonadjacent interproximal sites in two maxillar and two mandibular multi-rooted teeth by standardized filter paper strips. GCF samples were taken from four sites with GI \<1, PD ≤ 3, PBI =0 and CAL =0 in the H group; from four sites with GI ≥2, PD ≤3, PBI \>2 and CAL=0 in the G group; from four sites (deepest pockets 3 \<PD ≤5) with GI ≥2, PBI \>2 and 3 ≤CAL \<5 mm in P1 group; and from four sites (deepest pockets PD ≥5) with GI ≥2, PBI \>2 and CAL ≥5 mm in P2 group according to the baseline clinical measurements.
Serum sampling
Serum samples were taken following GCF sampling before the periodontal treatment. Six milliliters of venous blood were obtained by a standard venipuncture method and the serum was separated from blood by centrifugation at 1,500 g for 20 minutes.
Biochemical Assays
Levels of GCF ErbB4, Nrg4, IL-6, IL-10 and levels of serum ErbB4, Nrg4, nitric oxide synthase (NOS)2 and Arg1 were measured by the enzyme-linked immunosorbent assay (ELISA) using commercial kits according to the manufacturer's guidelines.
Statistical Analysis
All data analyses were performed using a statistical software package. Comparisons of clinical and biochemical parameters between the study groups were performed using the Kruskal- Wallis with Mann Whitney U test with Bonferroni correction method. The intragroup comparisons (at baseline and first month) were performed using Wilcoxon test for paired samples. Associations among levels of the GCF and serum biomarkers and clinical parameters were also examined using the Spearman rank correlation analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
stage II grade B periodontitis
GCF and serum samples were taken before and after treatment from stage II grade B periodontitis patients.
Intervention: Non- surgical periodontal treatment (SRP and oral hygiene instructions)
non surgical periodontal treatment
SRP under local anaesthesia, in a total of 2 clinical visits. Oral hygiene instructions including the modified Bass technique and an appropriate interdental cleaning device with dental floss and interdental brush.
Gingival crevicular fluid and serum collection
GCF with filter paper using the intracrevicular method and serum collection
stage III grade B periodontitis
GCF and serum samples were taken before and after treatment from stage III grade B periodontitis patients.
Intervention: Non- surgical periodontal treatment (SRP and oral hygiene instructions)
non surgical periodontal treatment
SRP under local anaesthesia, in a total of 2 clinical visits. Oral hygiene instructions including the modified Bass technique and an appropriate interdental cleaning device with dental floss and interdental brush.
Gingival crevicular fluid and serum collection
GCF with filter paper using the intracrevicular method and serum collection
gingivitis
GCF and serum samples were taken before and after treatment from gingivitis patients.
Intervention: Non- surgical periodontal treatment (Scaling and oral hygiene instructions)
non surgical periodontal treatment
SRP under local anaesthesia, in a total of 2 clinical visits. Oral hygiene instructions including the modified Bass technique and an appropriate interdental cleaning device with dental floss and interdental brush.
Gingival crevicular fluid and serum collection
GCF with filter paper using the intracrevicular method and serum collection
periodontally healthy
GCF and serum samples were taken at baseline from periodontally healthy individuals.
Gingival crevicular fluid and serum collection
GCF with filter paper using the intracrevicular method and serum collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
non surgical periodontal treatment
SRP under local anaesthesia, in a total of 2 clinical visits. Oral hygiene instructions including the modified Bass technique and an appropriate interdental cleaning device with dental floss and interdental brush.
Gingival crevicular fluid and serum collection
GCF with filter paper using the intracrevicular method and serum collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having at least 16 natural teeth (excluding third molar),
* Not having any diagnosed medical illness or drug intake that could affect the periodontal condition.
Exclusion Criteria
* Patients received nonsurgical or surgical periodontal treatment,
* Patients who have a restorative and endodontic therapy requirement,
* Having a removable partial denture and/or having orthodontic therapy,
* Current pregnancy or lactation,
* Obesity,
* Heavy smoking and having serum CRP \> 3mg/L .
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abant Izzet Baysal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sadiye Gunpinar
Asst. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sadiye Gunpinar, Asst. Prof.
Role: PRINCIPAL_INVESTIGATOR
Abant Izzet Baysal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bolu Abant Izzet Baysal University
Bolu, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, Flemmig TF, Garcia R, Giannobile WV, Graziani F, Greenwell H, Herrera D, Kao RT, Kebschull M, Kinane DF, Kirkwood KL, Kocher T, Kornman KS, Kumar PS, Loos BG, Machtei E, Meng H, Mombelli A, Needleman I, Offenbacher S, Seymour GJ, Teles R, Tonetti MS. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018 Jun;89 Suppl 1:S173-S182. doi: 10.1002/JPER.17-0721.
Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, Mealey BL, Papapanou PN, Sanz M, Tonetti MS. A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018 Jun;45 Suppl 20:S1-S8. doi: 10.1111/jcpe.12935.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018.06.05.1310
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2017/113
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.